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IN JULY 2012, the Journal of Studies on Alcohol and Drugs 
(JSAD) printed an exchange of ideas among Griffi th Ed-
wards (2012) in the United Kingdom and three members of 
the Substance Use Disorders Work Group of the Diagnostic 
and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-5; American Psychiatric Association, 2013): Debra 
Hasin (2012), Charles O’Brien (2012), and me (Schuckit, 
2012). In the ensuing year, the DSM-5 committee received 
additional input and discussed the fi nal format for the Sub-
stance-Related Disorders section, and the DSM-5 process 
drew to a close. The manual was released for general use in 
May 2013.
 This editorial follows up on that earlier correspondence to 
offer thoughts on the changes clinicians will see in the new 
DSM. It is important to note that the ideas I express here are 
my own and do not necessarily refl ect the views of JSAD 
or other members of the DSM-5 Substance-Related Disor-
ders Work Group. The good news is that the section on the 
substance-related disorders has few (if any) major changes, 
and the alterations that were made should be fairly easy to 
implement. However, before listing what you see in the new 
manual, I’d like to offer a bit of background.
 As I see it, the DSMs offer guidelines for clinicians deal-
ing with patients who have problems with any of nine dif-
ferent classes of drugs. To be useful for the busy clinician, 
the criteria must be straightforward and fl exible enough to 
be relevant to all nine drugs, older and younger individu-
als, men and women, and people from a range of cultural 
backgrounds. Therefore, almost by defi nition, the DSM is 
not a research manual. Researchers will need to consider 
the new criteria in light of complex interrelationships among 
genetic, environmental, developmental, and other forces 
that contribute to psychiatric conditions. They also need 
to “operationalize” and standardize the criteria by creating 
questions to evaluate each criterion item. I hope that, in the 
future, the national alcohol and drug institutes will consider 
developing standard wording for asking about each crite-
rion item both for self-administered questionnaires and for 
interviews and make them available to both researchers and 
clinicians for their consideration. This would increase the 
chance that we are all referring to the same issues when we 
screen for substance-related conditions. However, this step, 
as important and useful as it may be, is not the goal of the 
DSM itself.
Editor’s Corner: 
DSM-5—Ready or Not, Here It Comes
 The philosophy of the DSM-5 Substance-Related Disor-
ders Work Group was that changes from DSM-IV (American 
Psychiatric Association, 1994) to DSM-5 needed to be care-
fully evaluated. Any alteration could affect the relevance to 
future clinical work and research for the huge number of 
advances in knowledge that have accrued regarding DSM-
III-R in 1987 and DSM-IV in 1994 (the criteria for those 
two editions are quite similar). Therefore, changes to the 
diagnostic system needed to be supported by adequate data. 
A recent article by Hasin et al. (in press) and a letter to the 
editor (Hasin et al., 2013) describe the approaches used to 
evaluate data from more than 200,000 individuals that were 
available to the DSM-5 Work Group as we considered the 
assets and liabilities of possible alterations for DSM-5.
 Finally, in this brief introduction, the Work Group com-
pared the prevalence of persons diagnosed using DSM-5 
substance use disorders criteria with the prevalence of alco-
hol and other drug abuse and dependence using DSM-IV. As 
noted by Hasin et al. (in press), the prevalence rates across 
the two systems are quite similar.
 With that background, I turn to what I see as some of the 
most notable changes in DSM-5 and offer some thoughts 
about what needs to be done to prepare for future iterations 
of the diagnostic manual. To me, the major changes for sub-
stance use disorders in DSM-5 include the following:
 1. DSM-5 criteria for substance use disorders are less 
complicated than DSM-IV’s and are easier for the clinician 
to use. In DSM-IV, one needed to fi rst screen to see if three 
of seven dependence items clustered together in about the 
same year. If not, the clinician then needed to screen for 
clustering of four additional items to justify the diagnosis 
of abuse (in the absence of dependence). In the DSM-5 ap-
proach, 11 items are listed, and an individual is diagnosed 
with a substance use disorder if two or more criteria are 
endorsed for the same 12-month period. Thus, DSM-5 uses 
a one-step process compared with the two steps required 
in DSM-IV. Using a single criteria list also decreases the 
chance that someone will fall through the cracks between 
abuse and dependence (e.g., diagnostic orphans who met 
one or two dependence criteria but none for abuse and who, 
therefore, could not be diagnosed with either condition).
 2. Although DSM-IV offered guidelines of how to deter-
mine severity, these were rarely used in clinical settings. In 
contrast, DSM-5 offers clear and easy to implement rules 
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for mild, moderate, and severe substance use disorders, three 
categories that were mandated for every DSM-5 section. It is 
important to note that even the mild substance use disorder 
(two or three criteria endorsed) can only be diagnosed in the 
context of signifi cant impairment in life functioning or dis-
tress to the individual or those around them. Thus, this label 
indicates that an individual very likely needs treatment. The 
moderate (endorsement of three or four items) and severe 
(fi ve or more items) categories indicate more severe condi-
tions, but the distinction between impaired and not impaired 
rests with two or more items endorsed. A recent article by 
Compton et al. (2013) indicates that a mild substance use 
disorder has similarities to abuse in DSM-IV, whereas mod-
erate and severe conditions have parallels to dependence. 
The diagnostic numbering system for DSM-5 still uses the 
International Classifi cation of Diseases, Ninth Revision 
(ICD-9; World Health Organization, 1977), as was the case 
for DSM-IV.
 3. Modest progress was made to further simplify the 
diagnostic system by trying to delete items that were re-
dundant or rarely endorsed. As reviewed in the Hasin et al. 
(in press) article, the DSM-IV abuse item regarding legal 
problems was rarely endorsed and, if noted, was usually seen 
in the presence of additional diagnostic items; therefore, it 
was rarely an essential criterion for fulfi lling the diagnosis. 
Thus, the criterion regarding legal problems was deleted for 
DSM-5. At the same time, the Work Group was split on the 
importance of adding a criterion item for craving, with the 
majority feeling that craving added enough information to 
the criteria set regarding several of the drugs to be worth 
incorporating. Finally, several other potential redundancies 
among criterion items were observed, including the use 
of two separate criteria dealing with continuation of use 
of a substance despite psychosocial problems and despite 
physical or psychiatric problems. Similarly, there is potential 
overlap between two items relating to giving up important 
social, occupational, or recreational activities because of 
substance use and substance use resulting in failure to fulfi ll 
major role obligations at work, school, or home. However, 
these issues arose late in the DSM-5 process at a time when 
several new oversight committees were requesting additional 
documentation of the other changes that the Work Group 
had proposed. As a result, there was insuffi cient time left to 
carry out a full set of analyses regarding whether these four 
criterion items could be reduced to two. Prior evaluations 
by the Work Group did not clearly support removing these 
potentially redundant items from the list, and, in the absence 
of more defi nitive data, the full set of criteria remained at 11.
 4. The importance of substance-induced psychiatric 
syndromes originally amplifi ed in DSM-IV was maintained 
and expanded in DSM-5. Substance-induced depressions, 
psychotic episodes, anxiety conditions, and so on had been 
noted in one form or another since DSM-III (American Psy-
chiatric Association, 1980). DSM-IV in 1994 took steps to 
highlight these conditions that resemble independent psychi-
atric disorders (e.g., major depressive episodes) but, unlike 
the independent syndromes, are likely to improve and disap-
pear within a month of abstinence. The 1994 manual moved 
substance-induced intoxication, withdrawal, and substance-
induced psychiatric conditions from what was known as 
the “organic” disorders into the DSM-IV substance-related 
chapter and also listed these conditions in each relevant psy-
chiatric chapter (e.g., mood, anxiety, and psychosis disorders 
sections). That step paralleled how clinicians were likely to 
use DSM by looking through sections that might relate to the 
diagnosis being considered. In DSM-5, a similar approach 
is used, as the Substance-Related Disorders Work Group 
interacted closely with work groups for the other diagnostic 
issues (e.g., neurocognitive disorders, anxiety conditions, and 
mood disorders). There was equal input from experts in both 
committees as we compromised regarding the conditions to 
be listed, including the addition of substance-induced bipolar 
and obsessive–compulsive syndromes.
 5. Gambling disorder, listed with the impulse disorders in 
DSM-IV, was moved to the same section as the substance-
related disorders in DSM-5. To me, this was justifi ed by the 
fact that gambling disorder (previously known as pathologi-
cal gambling) did not fi t with the impulse disorders, because 
many problematic gamblers are not generally impulsive. Nor 
would it have been appropriate to place gambling syndromes 
with the mood conditions or the anxiety disorders, even 
though symptoms of those conditions are often seen in the 
context of gambling problems. At the same time, gambling 
disorder is a relatively prevalent, serious, and well-docu-
mented condition that needed to be listed somewhere within 
the manual, and, as a behavioral condition focusing on re-
petitive problems despite consequences, it was better suited 
to be listed with the substance use disorders section than 
anywhere else. However, placing it with the substance use 
disorders did not imply that we know that gambling disorder 
is just a variation of a substance use disorder. In fact, when 
an effort was made to replace the DSM-IV gambling criteria 
with the criteria set for substance use disorders, the gambling 
condition did not fi t appropriately into the substance use 
disorder framework, and it was decided to continue to use 
the gambling disorder criteria from DSM-IV (with slight 
modifi cations).
 Consistent with our worry that gambling and substance 
use conditions might not represent a unitary phenomenon, 
the Work Group voted to name our chapter “Substance-
Related Disorders and Gambling Disorder.” However, mem-
bers of a DSM-5 oversight committee disagreed and, against 
our advice, unilaterally changed the name of the chapter in 
DSM-5 to what fi nally became “Substance-Related and Ad-
dictive Disorders.” Our committee appealed that decision, 
but to no avail.
 Currently, I believe that no other repetitive behavioral 
condition has suffi cient data to justify adding new diagnoses 
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related to excessive Internet use; excessive Internet gaming; 
or excessive exercise, shopping, sex, and eating. My view is 
that until: (a) any such disorders have been reliably defi ned; 
(b) the clinical implications and clinical course have been 
clearly established; (c) data have accrued to demonstrate 
that the new condition is not a variant of an already well-
established diagnosis; and (d) data regarding life impairment 
and/or signifi cant distress have been published, no such 
diagnoses should be added into a manual. Even if these four 
criteria for a threshold are reached, careful thought must be 
given to whether such potential “behavioral addictions” are 
similar enough in etiology, course, and treatment to be listed 
with the substance use disorders, or if it is best to place them 
in a new section of their own.
 In closing, clinicians face relatively few challenges in 
adjusting from DSM-IV to DSM-5 substance use disorders. 
The major changes were clearly supported by data that dem-
onstrated more assets than liabilities to the new approach. 
At the same time, it is not too early to begin to think about 
future iterations of DSM-5 and for DSM-6. Issues may 
include evaluating whether additional items can be deleted 
from the criteria set and gathering appropriate data regarding 
the possible importance of repetitive harmful behaviors. An-
other issue relates to potential criteria for a Neurobehavioral 
Disorder Associated with Prenatal Alcohol Exposure (i.e., 
a fetal alcohol syndrome–like condition), which deserves 
future consideration and testing.
 These comments are just one person’s opinion. I invite 
people who have alternative views to write letters to the edi-
tor of JSAD, and I hope that a lively discussion develops.
MARC A. SCHUCKIT, M.D.
Editor, Journal of Studies on Alcohol and Drugs
Distinguished Professor of Psychiatry
University of California, San Diego
San Diego, CA
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